Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Asset Writedowns and Impairment of $1.3 million in Q1 2026, up 1115.62% quarter-over-quarter from -$128000.0 in Q4 2025, and down 24.68% on a YoY basis from $1.7 million in Q1 2025.
Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 24.68% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $2.2 million (down 25.23% YoY), while the FY2025 annual figure was $2.6 million, up 46.59% from the prior year.
- Asset Writedowns and Impairment was $1.3 million for Q1 2026 at Establishment Labs Holdings, up from -$128000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.7 million in Q1 2025 to a low of -$877000.0 in Q3 2022.
- Historically, Asset Writedowns and Impairment has averaged $512941.2 across 5 years, with a median of $287000.0 in 2023.
- Biggest YoY gain for Asset Writedowns and Impairment was 1135.34% in 2022; the steepest drop was 275.4% in 2022.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $1.2 million in 2022, then tumbled by 42.57% to $680000.0 in 2023, then soared by 48.82% to $1.0 million in 2024, then tumbled by 112.65% to -$128000.0 in 2025, then soared by 1115.62% to $1.3 million in 2026.
- The last three Asset Writedowns and Impairment figures came in at $1.3 million (Q1 2026), -$128000.0 (Q4 2025), and $810000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -128,000.00 |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 275,000.00 |
| Sep 30, 2024 | 275,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | 680,000.00 |
| Dec 31, 2023 | 680,000.00 |